213 related articles for article (PubMed ID: 30867224)
41. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
[TBL] [Abstract][Full Text] [Related]
42. Plasma Biomarkers Differentiate Parkinson's Disease From Atypical Parkinsonism Syndromes.
Lin CH; Yang SY; Horng HE; Yang CC; Chieh JJ; Chen HH; Liu BH; Chiu MJ
Front Aging Neurosci; 2018; 10():123. PubMed ID: 29755341
[No Abstract] [Full Text] [Related]
43. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
[TBL] [Abstract][Full Text] [Related]
44. Proteomic profiling of cerebrospinal fluid in parkinsonian disorders.
Constantinescu R; Andreasson U; Li S; Podust VN; Mattsson N; Anckarsäter R; Anckarsäter H; Rosengren L; Holmberg B; Blennow K; Wikkelsö C; Rüetschi U; Zetterberg H
Parkinsonism Relat Disord; 2010 Sep; 16(8):545-9. PubMed ID: 20620095
[TBL] [Abstract][Full Text] [Related]
45. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes.
Walter U; Niehaus L; Probst T; Benecke R; Meyer BU; Dressler D
Neurology; 2003 Jan; 60(1):74-7. PubMed ID: 12525721
[TBL] [Abstract][Full Text] [Related]
46. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study.
Pirker W; Djamshidian S; Asenbaum S; Gerschlager W; Tribl G; Hoffmann M; Brücke T
Mov Disord; 2002 Jan; 17(1):45-53. PubMed ID: 11835438
[TBL] [Abstract][Full Text] [Related]
47. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
Sjöström H; Granberg T; Westman E; Svenningsson P
Parkinsonism Relat Disord; 2017 Nov; 44():51-57. PubMed ID: 28886909
[TBL] [Abstract][Full Text] [Related]
48. Serum NFL discriminates Parkinson disease from atypical parkinsonisms.
Marques TM; van Rumund A; Oeckl P; Kuiperij HB; Esselink RAJ; Bloem BR; Otto M; Verbeek MM
Neurology; 2019 Mar; 92(13):e1479-e1486. PubMed ID: 30814322
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis.
Eusebi P; Giannandrea D; Biscetti L; Abraha I; Chiasserini D; Orso M; Calabresi P; Parnetti L
BMJ Open; 2016 Jun; 6(6):e011113. PubMed ID: 27297011
[TBL] [Abstract][Full Text] [Related]
50. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
[TBL] [Abstract][Full Text] [Related]
51. Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders.
Constantinescu R; Zetterberg H; Holmberg B; Rosengren L
Parkinsonism Relat Disord; 2009 Mar; 15(3):205-12. PubMed ID: 18562238
[TBL] [Abstract][Full Text] [Related]
52. "Atypical" atypical parkinsonism: Critical appraisal of a cohort.
Hirschbichler ST; Erro R; Ganos C; Stamelou M; Batla A; Balint B; Bhatia KP
Parkinsonism Relat Disord; 2017 Apr; 37():36-42. PubMed ID: 28236526
[TBL] [Abstract][Full Text] [Related]
53. A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson's disease.
Xiang C; Cong S; Tan X; Ma S; Liu Y; Wang H; Cong S
NPJ Parkinsons Dis; 2022 Nov; 8(1):165. PubMed ID: 36446820
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of Parkinson's disease and atypical parkinsonian syndromes in a rural Japanese district.
Osaki Y; Morita Y; Kuwahara T; Miyano I; Doi Y
Acta Neurol Scand; 2011 Sep; 124(3):182-7. PubMed ID: 20880268
[TBL] [Abstract][Full Text] [Related]
55. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
[TBL] [Abstract][Full Text] [Related]
56. CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes.
Constantinides VC; Paraskevas GP; Emmanouilidou E; Petropoulou O; Bougea A; Vekrellis K; Evdokimidis I; Stamboulis E; Kapaki E
J Neurol Sci; 2017 Nov; 382():91-95. PubMed ID: 29111028
[TBL] [Abstract][Full Text] [Related]
57. CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes.
Holmberg B; Johnels B; Ingvarsson P; Eriksson B; Rosengren L
Parkinsonism Relat Disord; 2001 Sep; 8(1):23-31. PubMed ID: 11472877
[TBL] [Abstract][Full Text] [Related]
58. Flt3 ligand does not differentiate between Parkinsonian disorders.
Silajdžić E; Constantinescu R; Holmberg B; Björkqvist M; Hansson O
Mov Disord; 2014 Sep; 29(10):1319-22. PubMed ID: 25044107
[TBL] [Abstract][Full Text] [Related]
59. Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease.
Trezzi JP; Galozzi S; Jaeger C; Barkovits K; Brockmann K; Maetzler W; Berg D; Marcus K; Betsou F; Hiller K; Mollenhauer B
Mov Disord; 2017 Oct; 32(10):1401-1408. PubMed ID: 28843022
[TBL] [Abstract][Full Text] [Related]
60. Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes.
Starhof C; Winge K; Heegaard NHH; Skogstrand K; Friis S; Hejl A
J Neuroinflammation; 2018 Nov; 15(1):305. PubMed ID: 30390673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
